"They raised 9 million , some of which should be allocated to midkine developments"
MJ have a look at note 26 (Segment Information) to the annual financials. It indicates that we spent in excess of $2.8m in the Midkine Division in the last financial year and a similar amount the previous year so funds are being allocated. I am in the same boat as some of the other posters - I invested in CDY because of their large pipeline of patents in the midkine area -and whilst I am happy to see the consumer health division powering ahead, I would like to see some real progress with midkine. However I do appreciate how long it takes to develop products in the biotech sector and am being very patient in the belief that it will pay off in the end.
CDY Price at posting:
36.0¢ Sentiment: Buy Disclosure: Held
